Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| SOHO | Sotherly Hotels | $2.15 | $1.25 | 140.93% | 7.3M | $18.2M | $0.59$2.15 |
| KITT | Nauticus Robotics | $2.80 | $1.04 | 59.34% | 27.6M | $10.0M | $1.73$54.36 |
| SUPV | Grupo Supervielle | $9.91 | $3.18 | 47.25% | 162.5K | $531.6M | $4.54$19.75 |
| GGAL | Grupo Financiero Galicia | $50.66 | $15.23 | 42.97% | 2.2M | $4.7B | $25.89$74.00 |
| BBAR | Banco Bbva Argentina | $14.45 | $4.34 | 42.93% | 77.1K | $2.1B | $7.76$25.01 |
| RNA | Avidity Biosciences | $70.17 | $21.02 | 42.77% | 15.3M | $7.2B | $21.51$70.39 |
| DYN | Dyne Therapeutics | $24.10 | $6.98 | 40.77% | 89.8K | $2.4B | $6.36$35.68 |
| EDN | Empresa Distribuidora Y Comercializadora Norte Sociedad Anónima | $27.08 | $7.70 | 39.73% | 26.2K | $428.5M | $14.38$51.69 |
| TGS | Transportadora De Gas Del Sur | $31.00 | $8.52 | 37.90% | 32.3K | $1.6B | $19.74$34.37 |
| BMA | Banco Macro | $78.50 | $21.02 | 36.57% | 54.6K | $3.6B | $38.30$118.42 |
Related Articles
Featured Article
3 Top Stocks That Could Still Rocket Higher in 2024
Cory Renauer|Oct 4, 2024
Upcoming Food and Drug Administration decisions could push these stocks through the roof.
2 Potentially High-Reward Growth Stocks to Buy Right Now
George Budwell|May 29, 2024
These two biotechnology stocks could be gearing up for a run.
2 Biotechs That Could Get Bought Out in 2024
George Budwell|Jan 3, 2024
These two biotechs have been frequent visitors to the buyout-rumor mill and for good reason.
Wall Street Thinks BridgeBio Pharma Could Rise Over 40% -- But Will It?
Alex Carchidi|Aug 9, 2023
Its potential upcoming drug launch might not be enough.
2 Nasdaq Stocks That Could Soar This Week
George Budwell|Jul 16, 2023
BridgeBio Pharma and Roivant Sciences could make big moves this week.
2 Growth Stocks With Major Incoming Catalysts
Cory Renauer|Jun 27, 2023
Binary events slated for July could quickly send these biotech stocks through the roof.
After Falling 18% in 1 Day, Is This Growth Stock Done For?
Alex Carchidi|Apr 11, 2023
It's too soon to predict doom, but that doesn't mean things are good.
These 2 Biotech Stocks Made Big Monday Moves
Dan Caplinger|Mar 6, 2023
Find out which was the winner and which was the loser.
Is BridgeBio Pharma Stock a Buy on the Dip?
Cory Renauer|Dec 29, 2021
This company's market value plunged by around $8 billion in 2021, leading contrarian investors to suspect a bargain opportunity.
Is Semler Scientific Stock Still a Buy After Its Earnings Miss?
Jamie Louko|Nov 4, 2021
The company reported slowing growth, but is there hope?
